Provided by Tiger Fintech (Singapore) Pte. Ltd.

Recursion Pharmaceuticals, Inc.

5.49
+0.920020.13%
Post-market: 5.570.0800+1.46%19:59 EDT
Volume:60.32M
Turnover:318.68M
Market Cap:2.23B
PE:-3.02
High:5.52
Open:4.72
Low:4.71
Close:4.57
Loading ...
Dec 17, 2024

Major Issues Report

Form 8-K - Current report
Dec 11, 2024

Proposed Sale Of Securities

Form 144 | RECURSION PHARMACEUTICALS Officer Michael Secora proposes to sell 15000 Shares, with a total value of approximately $112.18 Thousand.
Dec 10, 2024

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer Michael Secora proposes to sell 15000 Shares, with a total value of approximately $116,324
Dec 05, 2024

Proposed Sale Of Securities

Form 144 | Recursion Pharmaceuticals' Officer, Gibson Christopher, proposes to sell 20,000 shares, with a total value of approximately $142,400.
Dec 04, 2024

Proposed Sale Of Securities

Form 144 | RECURSION PHARMACEUTICALS, INC.'s Officer Gibson Christopher proposes to sell 20000 Shares, with a total value of approximately $143,200.
Dec 03, 2024

Major Issues Report

Form 8-K - Current report
Nov 27, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Nov 26, 2024

Major Issues Report

Form 8-K/A - Current report: [Amend]
Nov 21, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 20, 2024

Employee Stock Ownership

Form S-8 - Securities to be offered to employees in employee benefit plans
Nov 20, 2024

Major Issues Report

Form 8-K - Current report
Nov 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 13, 2024

Major Issues Report

Form 8-K - Current report
Nov 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 12, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Nov 06, 2024

Major Issues Report

Form 8-K - Current report
Nov 06, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]